Overview of recall records associated with Rising Pharma Holding, Inc., including dates, categories and classifications where available.
Classification mix: Class II: 5.
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength…
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
This page summarizes recall records in which the official source identifies Rising Pharma Holding, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.
